.1 May 2018 08:31
very nice rns... one to buy and hold (another one lol)
Stephen O'Hara, CEO of OptiBiotix, commented: "We are pleased that the strong science, successful human studies and international awards at major scientific conferences have attracted international commercial and media interest in LP-LDL�. This has allowed OptiBiotix to sign manufacturing, formulation/application and distribution partnerships with fast growing companies with leading market positions in multiple industry sectors across the world. We look forward to the opportunity of announcing deals with similar partners in the fast growing US marker once these have been concluded."